SM
Supriya Medapati
About Supriya Medapati
Data last updated:
Supriya Medapati is a Director at Aerolyma Private Limited (since 2022), Director at Vanko Biotech Private Limited (since 2019) and Director at Veneela Private Limited (since 2026). The companies operate in Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹9.4 Lakh; the largest is Aerolyma Private Limited at ₹6.6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Mar 2022 | 2022 | ₹6.6 Lakh (FY 2025) | Active | |
| Director | 25 Jan 2019 | 2019 | ₹2.8 Lakh (FY 2024) | Active | |
| Director | 06 Feb 2026 | 2026 | Active |
Board colleagues of Supriya Medapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Racharla Prasanna | 09554660 | Aerolyma Private Limited | Director |
| Venkata Surya Srinivasa Reddy Medapati | 08343113 | Vanko Biotech Private Limited | Director |
| Revathi Kolli | 11516905 | Veneela Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Supriya Medapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supriya Medapati
Supriya Medapati currently holds 3 directorships: Aerolyma Private Limited (Director, since 30 Mar 2022, revenue ₹6.6 Lakh (FY 2025)); Vanko Biotech Private Limited (Director, since 25 Jan 2019, revenue ₹2.8 Lakh (FY 2024)); Veneela Private Limited (Director, since 06 Feb 2026).
Supriya Medapati was first appointed on 25 Jan 2019 as Director at Vanko Biotech Private Limited. The most recent appointment on record is 06 Feb 2026 at Veneela Private Limited.
The 2 current companies of Supriya Medapati that report revenue have a combined latest revenue of ₹9.4 Lakh: Aerolyma Private Limited ₹6.6 Lakh (FY 2025); Vanko Biotech Private Limited ₹2.8 Lakh (FY 2024).
The current boards of Supriya Medapati's companies include Racharla Prasanna (Aerolyma Private Limited), Venkata Surya Srinivasa Reddy Medapati (Vanko Biotech Private Limited), Revathi Kolli (Veneela Private Limited).